The osteogenic differentiation of SSEA-4 sub-population of human adipose derived stem cells using silicate nanoplatelets by Mihaila, Silvia M. et al.
lable at ScienceDirect
Biomaterials 35 (2014) 9087e9099Contents lists avaiBiomaterials
journal homepage: www.elsevier .com/locate/biomater ia lsThe osteogenic differentiation of SSEA-4 sub-population of human
adipose derived stem cells using silicate nanoplatelets
Silvia M. Mihaila a, b, Akhilesh K. Gaharwar c, d, Rui L. Reis a, b, Ali Khademhosseini e, f, g, h, i,
Alexandra P. Marques a, b, Manuela E. Gomes a, b, *
a 3B's Research Group e Biomaterials, Biodegradables and Biomimetics, University of Minho, Avepark e Zona Industrial da Gandra, S. Claudio do Barco,
4806-09, Caldas das Taipas, Guimar~aes, Portugal
b ICVS/3B's e PT Government Associate Laboratory, Braga, Guimar~aes, Portugal
c Department of Biomedical Engineering, Texas A&M University, College Station, TX 77843, USA
d Department of Materials Science & Engineering, Texas A&M University, College Station, 77843, USA
e Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA
f Center for Biomedical Engineering, Department of Medicine Brigham and Women's Hospital, Harvard Medical School, Cambridge, 02139, USA
g Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
h Department of Maxillofacial Biomedical Engineering and Institute of Oral Biology, School of Dentistry, Kyung Hee University, Seoul 130-701,
Republic of Korea
i Department of Physics, King Abdulaziz University, Jeddah 21569, Saudi Arabiaa r t i c l e i n f o
Article history:
Received 19 June 2014
Accepted 23 July 2014
Available online 12 August 2014
Keywords:
Human adipose derived stem cells
SSEA-4þhASCs subpopulation
Silicate nanoplatelets
Osteogenic differentiation
Bone tissue engineering* Corresponding author. 3B's Research Group e Biom
Biomimetics, University of Minho, Avepark e Zona Ind
do Barco, 4806-09, Caldas das Taipas, Guimar~aes, Por
fax: þ351 253 510909.
E-mail address: megomes@dep.uminho.pt (M.E. G
http://dx.doi.org/10.1016/j.biomaterials.2014.07.052
0142-9612/© 2014 Elsevier Ltd. All rights reserved.a b s t r a c t
How to surpass in vitro stem cell differentiation, reducing cell manipulation, and lead the in situ
regeneration process after transplantation, remains to be unraveled in bone tissue engineering (bTE).
Recently, we showed that the combination of human bone marrow stromal cells with bioactive silicate
nanoplatelets (sNPs) promotes the osteogenic differentiation without the use of standard osteogenic
inductors. Even more, using SSEA-4þ cell-subpopulations (SSEA-4þhASCs) residing within the adipose
tissue, as a single-cellular source to obtain relevant cell types for bone regeneration, was also proposed.
Herein, sNPs were used to promote the osteogenic differentiation of SSEA-4þhASCs. The interactions
between SSEA-4þhASCs and sNPs, namely the internalization pathway and effect on cells osteogenic
differentiation, were evaluated. SNPs below 100 mg/mL showed high cytocompatibility and fast inter-
nalization via clathrin-mediated pathway. SNPs triggered an overexpression of osteogenic-related
markers (RUNX2, osteopontin, osteocalcin) accompanied by increased alkaline phosphatase activity
and deposition of a predominantly collagen-type I matrix. Consequently, a robust matrix mineralization
was achieved, covering >90% of the culturing surface area. Overall, we demonstrated the high osteogenic
differentiation potential of SSEA-4þhASCs, further enhanced by the addition of sNPs in a dose dependent
manner. This strategy endorses the combination of an adipose-derived cell-subpopulation with inorganic
compounds to achieve bone matrix-analogs with clinical relevance.
© 2014 Elsevier Ltd. All rights reserved.1. Introduction
Bone tissue engineering (TE) requires a readily available source
of cells, combined with cell-templates (scaffolds) providing bio-
instructive agents (inductive and/or growth factors, cytokines) to
trigger and control the osteogenic phenotype and consequently anaterials, Biodegradables and
ustrial da Gandra, S. Claudio
tugal. Tel.: þ351 253 510906;
omes).adequate biological functionality. Osteoinductivity is the key pro-
cess to induce the differentiation of osteoprogenitor cells into
osteoblast cells to eventually form new bone. Thus, extensive
research has been focused on determining the appropriate condi-
tions to trigger osteoinductive events. A range of inorganic bioac-
tive materials such as bioactive glasses, calcium phosphates (CaPs)
[1], hydroxyapatite (HA), beta tri-calcium phosphates (b-TCP) [2],
and orthosilicic acid (Si(OH)4) [3] are exploited as osteoinducers
[4]. However, due to their limited processability and insufﬁcient
degradation, there is a need to develop a new generation of
bioactive materials.
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materials such as synthetic silicates [5,6] and graphene [7],
suggesting unexploited routes for biomaterials design and
regenerative medicine. In particular, bioactive silicate nano-
platelets (sNPs) based on synthetic silicate (Laponite,
Naþ0:7½ðMg5:5Li0:3ÞSi8O20ðOHÞ40:7) have shown to induce osteo-
genic differentiation of bone marrow human mesenchymal stem
cells (hMSCs) in the absence of osteoinductive factors, such as
BMP-2 or dexamethasone [6]. A single dose of these sNPs en-
hances the osteogenic differentiation of hMSCs, when compared
to hMSCs cultured in standard osteogenic differentiation condi-
tions (in the presence of dexamethasone). Moreover, these syn-
thetic silicates have shown to physically interact with both
synthetic and natural polymers and can be used as injectable
matrices for cellular therapies [8e11]. Although these ﬁndings
foster the development of new bioactive nanomaterials for bone
TE [5,8,12,13], limited availability of bone marrow hMSCs, inva-
sive retrieval procedures and high donor-site morbidity
compromise the clinical applicability of the sNPs combined with
these cells.
Recently, human adipose derived stem cells (hASCs) isolated
from the stromal vascular fraction (SVF) of adipose tissue (AT) have
emerged as one of the most promising stem cell populations
identiﬁed thus far [14,15]. Moreover these cells have the ability to
differentiate along multiple lineage pathways as reported in liter-
ature [14,15]. From a practical standpoint, human AT is abundant
and easily obtained in large quantities with low donor-site
morbidity or patient discomfort. The use of autologous hASCs as a
research tool and as basis of cellular therapeutic strategies is
feasible, making them preferential cells for TE, compared to bone
marrow hMSCs. Furthermore, considering the limitations of hASCs
in terms of differentiation potential (osteogenic [16], chondrogenic
[16], adipogenic [16], myogenic [16] and neurogenic [17]), recent
studies have shown that a selected and enriched cellular subset has
signiﬁcantly higher differentiation potential. For instance, STRO-
1þhASCs [18], CD105hASCs [19], CD90þhASCs [18,20] and
p75þhASCs [18] were found to exhibit higher osteogenic potential
when compared to hASCs. Nonetheless, considering that the ma-
jority of biological systems rely on the different cellular in-
teractions, it is important to classify a cell source that can act as
starting point for several differentiation pathways. Thus, the
isolation of cells fromAT is relevant for bone TE andmore appealing
for clinical translation.
In our previous work [21], we have shown that SVF of the hu-
man AT, contains a subpopulation deﬁned by their positive
expression of the pluripotency-associated marker, SSEA-4 that is
capable of differentiating into mature microvascular-like endo-
thelial cells. Interestingly, this cell subpopulation also showed a
superior potential to differentiate towards the osteogenic lineage,
compared to hASCs. Therefore, ATcan be used as a single cell source
to obtain a sub-population of cells, SSEA-4þhASCs, that under
speciﬁc conditions give rise to endothelial- and osteoblast-like
cells, further reinforcing its relevance in designing bone-
mimicking constructs.
Herein, we propose to use sNPs to promote and induce the
osteogenic differentiation of SSEA-4þhASCs by intracellular inter-
play, as well as through direct cellular interactions. We hypothesize
that the addition of sNPs to SSEA-4þhASCs induces osteogenic
differentiation of SSEA-4þhASCs. The combination of cells with
high potential towards osteogenic differentiation with inorganic
compounds that are able to sustain and improve the extent of
mineralization can be a potential avenue towards formation of
functional bone tissue. This approach up-holds the promise of
developing feasible solutions for the induction of higher levels of
new bone formation.2. Materials and methods
2.1. Hydrodynamic diameter and surface charge of sNPs
Laponite silicate nanoplatelets (sNPs, Naþ0:7½ðMg5:5Li0:3ÞSi8O20ðOHÞ40:7, Rock-
wood, USA) were dissolved in ultrapure water at different concentrations (<10 mg/
mL). The hydrodynamic diameter and zeta potential of the sNPs were measured by
photon correlation spectroscopy and laser Doppler anemometry, respectively, using
a Malvern Zetasizer Nano ZS (Malvern Instruments, UK). Each analysis was per-
formed at 25 C, with a detection angle of 90 and a refractive index of 1.5 (for
inorganic particles). Each formulation was analyzed in triplicate.
2.2. SSEA-4þhASCs selection and culture
Human abdominal subcutaneous AT samples were obtained from healthy fe-
male with an average age of 44 years, undergoing lipoaspiration procedure, after
informed consent. The retrieval and transportation of the samples to the 3B's
Research Group laboratorial facilities were performed under a protocol previously
established with the Department of Plastic Surgery of Hospital da Prelada, Porto,
Portugal and approved by the local Ethical Committee. All the samples were pro-
cessed within 24 h after the surgical procedure, as previously described [21]. Brieﬂy,
the AT was digested with 0.05% (wt/v) collagenase II A (Sigma, Germany) in phos-
phate buffer saline (PBS), for 45 min, under agitation in a shaking bath at 37 C. The
digested tissue was ﬁltered through a 200 mm mesh pore size strain, followed by
centrifugation to remove the mature adipocytes and undigested connective tissue.
After performing lysis to disrupt the red blood cells, the crude was centrifuged and
resuspended in PBS to obtain the SVF.
The immunomagnetic selection of the SSEA-4þhASCs was performed based on
the coating of commercially available magnetic beads (Dynabeads® M-450 Epoxy
beads, Invitrogen, USA) with SSEA-4 (clone MC813) antibody (Santa Cruz Biotech-
nology, USA) following the manufacturer's instruction and as previously reported
[21]. Brieﬂy, 2  107 immunomagnetic beads resuspended with 10 mL of the SSEA-4
antibody at a ﬁnal concentration of 2 mg/mL, and then incubated, overnight, at room
temperature, under gentle stirring. Subsequently, the SSEA-4 coupled beads were
separated with a magnet and mixed with freshly isolated SVF in order to select the
SSEA-4þ cells residing within the cell crude (SSEA-4þhASCs). The cells bonded to the
beads were separated from the rest of the cell suspension using the magnet.
The SVF and the SSEA-4þhASCs were both cultured with basal medium (Mini-
mum Essential Medium Eagle-alpha Modiﬁcation, a-MEM, Gibco, USA), supple-
mented with sodium bicarbonate (Sigma, Germany), 10% fetal bovine serum (FBS,
Gibco, USA) and 1% penicillin/streptomycin (Pen/Strep, 100 U/100 mg/mL, Gibco,
USA). When reaching 80% conﬂuence, cells were detached from the culture ﬂasks
using TrypLE™ Express (Invitrogen, USA) and kept under the same conditions along
the passages. Both cell subgroups were used at passage 2 for further experiments.
2.3. SNPs cytotoxicity screening
The effect of sNPs on cells metabolic activity was investigated by monitoring
metabolic activity of adhered SSEA-4þhASCs (passage 2), cultured in basal medium,
for a period of 7 days. Cells were seeded in 48-well plates at a density of 2103 cells/
cm2 and sNPswere added to a ﬁnal concentration ranging from 0 to 2mg/mL. At pre-
selected time points, cells were washed thoroughly with PBS, and a mixture of
serum- and phenol-red free culture medium and MTS reagent (Promega, USA) in a
5:1 ratio, was added to the cells. Samples were incubated for 3 h, after which 100 mL
of each sample were transferred to 96-well plates and optical density (OD) at
490 nm was measured on a microplate reader (Synergy HT microplate reader, Bio-
tek, USA). The metabolic activity of the test groups was normalized with the control
group (cells without sNPs) to determine the dose response. Aiming at further
assessing the effect of the sNPs over cells cytoskeleton organization, cells were ﬁxed
with formalin and stained with Phalloidin-TRITC (Sigma, USA) for visualization of
the F-actin ﬁlaments.
2.4. Assessment of internalization efﬁciency of sNPs by SSEA-4þhASCs
The sNPs were labeled with rhodamine B prior to assessing their internalization
ability. For this purpose, 2 g of sNPs were added to 100 mL of 0.1% (wt/v) of
rhodamine B isothiocyanate (Sigma, Germany) solution prepared in anhydrous
DMSO, in dark conditions. The mixture was kept under continuous stirring, over-
night, at 4 C. Several washing steps with absolute ethanol were performed in order
to separate the sNPs from the organic phase and excess rhodamine B. Finally, sNPs
were air-dried and kept at room temperature, protected from light, until further
used.
The SSEA-4þhASCs (passage 2) were seeded at a cell density of 2  103 cells/cm2
and allowed to adhere. After 24 h, rhodamine-labeled sNPs (1, 10, 20, 50, 100 and
200 mg/mL) were added to the culture wells and cultures were maintained in basal
medium, in the presence/absence of 106 M colchicine, for additional 24 h. SSEA-
4þhASCs cultured in basal medium in the presence of colchicine, but without the
sNPs, were used as negative control. Cells were then washed thoroughly with PBS,
trypsinized and ﬁxed with acquisition buffer (PBS containing 10% formalin and 0.1%
sodium azide) and 10% formalin respectively for analysis in a FACS Calibur ﬂow
cytometer (BD Biosciences, USA). In the ﬂow cytometry analysis cells of interest
Fig. 1. Experimental setup depicting the temporal approach followed to induce the osteogenic differentiation of SSEA-4þhASCs. After selection from the freshly isolated SVF, SSEA-
4þhASCs were cultured in basal medium up to passage 2, then seeded at a density of 2000 cells/cm2 and allowed to adhere for 24 h until the sNPs were added. Cultures were
maintained either in basal medium or under osteogenic differentiation conditions. At pre-selected time points (days 7, 14, 21 and 28) samples were retrieved to assess the extent of
differentiation.
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were displayed as histogram plots created using the CellQuest software (BD Bio-
sciences, USA). Apart from that, for rhodamine samples ﬁxed on coverslips, cell
nuclei were counterstained with 4,6-diamidino-2-phenyindole dilactate (DAPI).
Samples were visualized and images were acquired using the Axioplan Imager Z1
ﬂuorescence microscope (Zeiss, Germany) and the AxioVision 4.8 software (Zeiss,
Germany).
2.5. Osteogenic differentiation
Conﬂuent SSEA-4þhASCs (passage 1) were removed from the culture ﬂasks
using TrypLE™ Express (Invitrogen, USA) and seeded at a density of 2  103 cells/
cm2 in basal medium. Cells were allowed to adhere and after 24 h, medium was
replaced with either sNPs-containing (1, 10 and 100 mg/mL) basal medium or oste-
ogenic medium (osteo) consisting in basal medium supplemented with 10 mM beta-
glycerophosphate (Sigma, Germany), 108 M dexamethasone (Sigma, Germany), and
50 mg/mL L-ascorbic acid 2-phosphate sesquimagnesium salt hydrate (Sigma, Ger-
many). Cells were incubated in a humidiﬁed environment at 37 C with 5% CO2 for 7,
14, 21, and 28 days, with culture media replenishment every 3e4 days. SSEA-
4þhASCs and hASCs cultured in basal and osteo media in the absence of sNPs were
used as controls. The experimental setup is depicted in Fig. 1.
2.6. Cell number quantiﬁcation
The amount of double strained DNA (dsDNA), that is directly proportional with
the cell number, was determined using a ﬂuorometric dsDNA quantiﬁcation kit
(PicoGreen, Molecular Probes, Invitrogen, USA), according to the manufacturer's
instructions. Samples collected at days 7, 14, 21 and 28 of culture were subjected to
thermal and osmotic shocks to lyse the cells. Cell lysates were then used for the
dsDNA quantiﬁcation. Fluorescencewasmeasured using an excitationwavelength of
480 nm and emission wavelength of 538 nm in a microplate reader (Synergy HT,
Biotek, USA). Standards were prepared at a concentration ranging between 0 and
2 mg/mL. Triplicates were made for each sample and per condition.
2.7. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR)
2.7.1. RNA extraction and cDNA production
mRNA was extracted using TRI Reagent/ (Sigma, Germany), following the
manufacturer instructions. Proteins were extracted using chloroform and the RNA
pellets were washed with isopropyl alcohol and 70% ethanol. The total mRNA was
reconstituted in RNAse-free water (Gibco, USA). mRNA quantity and purity were
assessed with a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies,
USA). First-stranded complementary DNA (cDNA) synthesis was performed usingTable 1
Primer pair sequences for the studies genes.
Gene Sequences
Forward (50/30)
GAPDH ACAGTCAGCCGCATC
RUNX2 TTCCAGACCAGCAGCACTC
OPN GGGGACAACTGGAGTGAAAA
OCN CTGGAGAGGAGCAGAACTGGqScript™ cDNA synthesis Kit (Quanta BIosciences, USA) on a Mastercycler ep real-
plex thermal cycler (Eppendorf, USA). An initial amount of 1 mg of mRNAwas used in
a total volume of 20 mL.
2.7.2. Quantitative real time RT-PCR
The quantiﬁcation of the transcripts of the genes of interest was carried out by
RT-PCR using 50 ng of cDNA and PerfeCTA™ SYBR® Green FastMix kit (Quanta
Biosciences, USA) following the procedure suggested by the manufacturer. The
primers were previously designed using the Primer 3 online software (v0.4.0,
Whitehead Institute, USA) and synthesized by MGW Biotech (Germany). For each
sample, the transcripts expression data were normalized to glyceraldehyde-3-
phosphate-dehydrogenase (GAPDH) as housekeeping gene. The primers sequences
and annealing and annealing temperatures for bone-speciﬁc genes, Runt-related
transcription factor 2 (RUNX2), osteocalcin (OCN) and osteopontin (OPN), and for
GAPDH are described in Table 1. A concentration of 100 nM of primer was used in a
ﬁnal volume of 20 ml of sample. Reactions were performed in a real-time Master-
cycler ep realplex thermal cycler (Eppendorf, USA). The relative quantiﬁcation of the
targeted genes was performed using the 2DDCT method [22]. The transcripts
expression data were ﬁrst normalized against endogeneous GAPDH values and then
against the values of hASCs cultured in basal or osteo medium, respectively for basal
and osteo conditions.
2.8. Alkaline phosphatase activity quantiﬁcation and staining
The alkaline phosphatase (ALP) activity was measured on the cell lysates ob-
tained for dsDNA quantiﬁcation, using an adapted end-point colorimetric procedure
based on the p-nitrophenol (pNP) assay. Brieﬂy, 20 mL of lysate were incubated with
80 mL p-nitrophenol phosphate solution (pNPP, 0.2% wt/v in 1 M diethanolamine,
Fluka BioChemika, Austria). A calibration curve was prepared using the pNP stan-
dards (Sigma, Germany) with values ranging from 0 to 0.5 mmol/mL. The OD of the
samples and standards was read at 405 nm, using a microplate reader (Synergy HT,
Biotek, USA). Triplicates of each sample and standard were made, and the ALP ac-
tivity was read off from the standard curve. Results were normalized against dsDNA
results obtained for the same samples. The qualitative detection of ALP was per-
formed by staining the ﬁxed samples with nitro-blue tetrazolium/indolylphosphate
(NBT/BCIP, Thermo Scientiﬁc, USA). Samples were visualized and images were ac-
quired as described above.
2.9. Collageneous and non-collageneous protein staining and quantiﬁcation
The presence and distribution of collagen and non-collagenous proteins within
the extracellular matrix (ECM) were determined by differential staining with two
dyes, Sirius Red and Fast Green. Sirius Red binds speciﬁcally to collagen, whereasNCBI reference
Reverse (30/50)
GACAAGCTTCCCGTTCTCAG NM_002046.4
CAGCGTCAACACCATCATTC NM_001145920.1
CCC ACAGACCCTTCCAAGTA NM_001040058
GGCAGCGAGGTAGTGAAGAG NM_099173
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deposition was assessed using the micro-assay kit (Chondrex, USA). Brieﬂy, a
mixture of 0.1% Sirius Red and 0.1% Fast Green solution saturated with picric acid
was added to the ﬁxed samples. After 30 min, the dye was removed and samples
rinsed with distilled water. Stained samples were visualized and images were ac-
quired as described above.
For the quantiﬁcation the dyes were extracted from the stained samples using
0.05 M NaOH solution in methanol and the OD measured at 540 nm (Sirius Red) and
605 nm (Fast Green). The amount of collagenous and non-collageneous proteins was
calculated according to the manufacturers indications and normalized against the
dsDNA of the corresponding samples.
2.10. Immunocytochemistry for collagen I and II
Samples were washed and ﬁxed with 10% formalin for 20 min, washed again
with PBS and blocked with a 1.5% BSA/PBS solution. Cells were incubated for 1 h at
room temperature with the primary antibodies, mouse anti-human collagen I
(abcam, ab90395, UK) and mouse anti-human collagen II (abcam, ab34712, UK). All
antibody dilutions were performed in 1.5% BSA/PBS. Upon this incubation, cells were
washed three times with PBS and incubated with the appropriate secondary anti-
body, either goat anti-mouse Alexa Fluor 488 (Invitrogen, USA), or donkey anti-
mouse Alexa Fluor 594 (Invitrogen, USA) diluted 1:500 in 1.5% BSA/PBS. Cell
nuclei were counterstainedwith DAPI, at a 1:10,000 dilution in PBS. Negative control
samples were prepared by replacing the primary antibody incubation with PBS.
Samples were visualized and images were acquired as described above.
2.11. Alizarin Red staining and quantiﬁcation
Staining with Alizarin Red was performed in order to assess calcium deposition.
The cells were ﬁxed with 10% formalin, for 20 min, and washed prior staining with
PBS and, again with distilled water to remove any contaminating salts. A 2% (wt/v)
Alizarin Red solution (Sigma, Germany) was added and 10 min after, the cells were
washed with distilled water and imaged as previously described. Subsequently, in
order to obtain quantitative data, the extraction of the dye from the stained cell
monolayer was performed by the addition of a 10% (v/v) acetic acid (vWR, Portugal).
The dissolved samples were transferred to microcentrifuge tubes, centrifuged and
neutralized with 10% (v/v) ammonium hydroxide (Sigma, Germany). Finally, 100 mL
of each sample was transferred in 96-well plate and the absorbance was read atFig. 2. Physical properties of the sNPs. (A) The sNPs, with the Naþ0:7½ðSi8Mg5:4Li0:3ÞO20ðOHÞ4
distribution (negatively charged facets and positively charged sides). Due to surface charg
aggregation. (BeC) Box plots depicting the sNPs hydrodynamic diameter and zeta potential
increased concentrations, strong van der Waals forces make the sNPs to adhere to each o
***p < 0.001).405 nm. A calibration curve was obtained from different concentrations of Alizarin
Red in distilled water at pH ¼ 4.2, adjusted with 10% (v/v) ammonium hydroxide.
2.12. Statistical analysis
Statistical analysis was performed using GraphPad Prism 5.00 software (San
Diego, USA). Each experiment was carried out three times independently and per-
formedwith at least three replicates. First, a ShapiroeWilk testwas used to ascertain
the data normality. The results indicated that non-parametric test should be
employed for all comparisons. Statistical signiﬁcances were determined using one-
way analysis of variance (ANOVA), followed by post hoc Tukey test for all pair-wise
mean comparisons, with the limit for statistical signiﬁcance being deﬁned as
p < 0.05.
3. Results
3.1. SNPs characterization
Silicate nanoplateletes (sNPs) are synthetic disc-shaped crystals,
characterized by a high aspect ratio (25e30 nm in diameter and
1 nm in width) and with an empirical formula given by
Naþ0:7½ðSi8Mg5:4Li0:3ÞO20ðOHÞ40:7 (Fig. 2A). The unit cell of the
crystal is comprised of layers of [SiO4] tetrahedral sheets of Mg2þ,
which complement their octahedral coordination by bridging with
OH groups. The partial substitution of Mg2þ in the octahedral
sheets by Liþ, charges the faces of the sNPs negatively, so that Naþ
ions are accommodated between the faces of the platelets for
charge compensation, leading to a deﬁned spatial distribution of
charge on the sNPs [23].When sNPs are dispersed in distilled water,
the Naþ ions are released into the solution leading to the formation
of a double layer that causes the particles to electrostatically repeal
each other, hence stabilizing them in overall negative charge of
10e15 mV. However, with the increase of concentration (>100 mg/
mL), a signiﬁcant increase in the overall size of the sNPs,
0:7 empirical formula, are characterized by a high aspect ratio (25:1 to 30:1) and charge
e, upon dispersion in distilled water, sNPs electrostatically repel each other, avoiding
. In dilute suspension, the sNPs are well dispersed and negatively charged. However, at
ther, such as in the mechanism of ﬂocculation or aggregation (*p < 0.05, **p < 0.01,
S.M. Mihaila et al. / Biomaterials 35 (2014) 9087e9099 9091accompanied by a slight decrease of the overall charge, was
observed (Fig. 2BeC).3.2. Cells and sNPs interactions and potential internalization
mechanism
The potential cytotoxic effects of the sNPs were assessed after
exposing the SSEA-4þhASCs to different concentrations of sNPs
over a period of 7 days. MTS test was performed to assess the
metabolic activity of cells in the presence of sNPs. The addition of
up to 100 mg/mL sNPs to the cells did not cause changes in their
metabolic activity, however at concentrations (ranging from 250 to
10,000 mg/mL) an abrupt decrease in the metabolic activity of cells
was observed (Fig. 3A). Moreover, SSEA-4þhASCs cultured in the
presence of sNPs at concentrations lower than 100 mg/mL displayed
a homogeneous ﬁbroblast-like morphology characteristic of
mesenchymal cells (Fig. 3B and Supplemental Fig. 1). However, at
high concentrations (>100 mg/mL), small sNPs clusters were
observed on the surface of the cells. At those concentrations, cells
were covered with a gel-like aggregate that lead to an apparent
shrinkage of the cells cytoskeleton (Supplemental Fig. 1). Previous
report also indicates that sNPs concentration of <100 mg/mL does
not result in signiﬁcant production of reactive oxygen species (ROS)
and reactive nitrogen species (RNS), indicating the cytocompatible
nature of sNPs [12]. Thus, for further experiments, it was decided
not to consider sNPs concentrations higher than 100 mg/mL, as
these lead to a reduction of cells metabolic activity greater than 20%
and signiﬁcant cellular morphological alterations.Fig. 3. Dependence of cellular behavior with sNPs concentration. (A) Metabolic activity o
percentage of metabolic activity of SSEA-4þhASCs in the presence of sNPs in relation to the
time point (average ± SD, n ¼ 3). The metabolic activity threshold for choosing the approp
inhibitory activity (IC50) was found at a concentration of 1 mg/mL. (B) Cytoskeleton (F-actin ﬁ
not alter the morphology of the cells. Small sNPs aggregates can be observed on the surface o
color in this ﬁgure legend, the reader is referred to the web version of this article.)Labeled sNPs were internalized and widely distributed in the
cell cytoplasm, around the cells nuclei (Fig. 4A), but also attached to
the cell membranes (Supplemental Fig. 1). In order to elucidate the
internalization mechanism and deplete internalization from
external contact of the cells with the sNPs, cells were cultured in
the presence of rhodamine-labeled sNPs and colchicine, an endo-
cytotic restrictive drug, for a period of 24 h. When cells were
cultured in the absence of colchicine (green peak), a strong shift
was observed, which is associated with cell-sNPs interaction
derived from ﬂuorescent sNPs externally attached to the cells, as
well as internalized (Fig. 4B). At high concentration of sNPs
(100e250 mg/mL), more than 80% of cells interacted with the sNPs.
However, in the presence of colchicine, there was a noticeable
decrease (white peak). At high concentrations, only 30% of the cells
were positive (interacting with the sNPs). Considering the differ-
ence between the results with and without colchicine as the
internalization efﬁciency, with the premise that the internalization
of the sNPs is solely endocytotic, the internalization efﬁciency
ranges from 5% for 1 mg/mL and can reach 40% for 100 mg/mL of
sNPs (Fig. 4C).
3.3. SNPs effect on the SSEA-4þhASCs osteogenic differentiation
Prior differentiation, SSEA-4þhASCs were characterized as pre-
viously described [21] for the expression of surface markers such as
CD105, CD90, CD73, CD45 and CD34. The cells showed
mesenchymal-like phenotype, displaying the characteristic
multiple-parametric pattern [24]: CD90þ/CD105þ/CD73þ/CD45/
CD34 (Supplemental Fig. 2).f cells in the presence of different concentrations of sNPs. Results are presented as
metabolic activity of SSEA-4þhASCs cultured without sNPs (control) at the considered
riate sNPs concentrations was set to 80% in relation to the control. The half maximal
bers) organization (red) upon addition of sNPs. The addition of sNPs (<100 mg/mL) does
f the cells, for higher concentrations of the sNPs. (For interpretation of the references to
Fig. 4. Internalization of sNPs by SSEA-4þhASCs. (A) Fluorescence microscopy images of cells cultured in the presence of rhodamine-labeled sNPs (red) for 24 h. Rhodamine-labeled
sNPs were found distributed in the cell cytoplasm, around the cells nuclei (blue). (B) Flow cytometry data of cells interacting with the in the presence (white) or absence (green) of
colchicine. Cells without sNPs were used as negative control (purple). (C) Quantiﬁcation of the internalization (yellow) by subtracting the sNPs-cell interaction in the presence of
colchicine (white) from the total sNPs-cell interaction (without colchicine, green). The internalization efﬁciency ranges from 5% for 1 mg/mL and can reach 40% for 100 mg/mL of
sNPs. Abbreviation: w/ ¼ with, w/o ¼ without. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
S.M. Mihaila et al. / Biomaterials 35 (2014) 9087e909990923.3.1. The effect the expression of RUNX2, OPN and OCN transcripts
in SSEA-4þhASCs cultures
The acquisition of an osteogenic phenotype by SSEA-4þhASCs
when the culturing with sNPs was evaluated by following the
expression levels of RUNX2, OCN and OPN genes. In basal medium,
no fold changes were observed concerning any of the studied genes
for SSEA-4þhASCs, when compared to hASCs cultured in the same
medium. However, with the addition of sNPs, a 2-fold increase for
RUNX2 and OPN, and of 8- for OCN was noticed (***p < 0.001,
Fig. 5A). For instance, a signiﬁcant up-regulation of RUNX2 occurred
at day 7 for the higher sNPs concentration. This effect was suc-
cessively delayed to days 14 and 21, when cells were cultured with
10 and 1 mg/mL sNPs, respectively. Concomitantly, the OPN
expression is signiﬁcantly increased at day 14 for the 10 and 100 mg/
mL sNPs, followed by an immediate decrease to basal levels, while a
signiﬁcant up-regulation of OCN occurred at day 21 for all sNPs
concentrations.
In osteogenic medium, there was a clear difference in the
osteogenic performance between hASCs (control) and SSEA-
4þhASCs. A signiﬁcant up-regulation of RUNX2, OPN and OCN gene
transcripts was observed for SSEA-4þhASCs (**p < 0.01). After
reaching a maximum (day 7 for RUNX2, day 14 for OPN, day 21 for
OCN), a down-regulation reaching baseline levels of hASCs control
cultures was observed (Fig. 5B). The addition of sNPs further
increased the up-regulation of the genes of interest in such a
manner that the 100 mg/mL sNPs induced a 70-fold increase(*p < 0.05) in the expression of RUNX2 at day 7, a 9-fold increase
(*p < 0.01) for OPN at day 14 and 45-fold increase (*p < 0.01) for
OCN at day 21 in relation to both the hASCs control cultures and
SSEA-4þhASCs in the absence of the sNPs.
3.3.2. The effect of sNPs over ALP activity
The osteogenic differentiation of the SSEA-4þhASCs under the
different culture conditions was conﬁrmed, by qualitative and
quantitative assessment of the levels of ALP activity, an early
marker of differentiation, along the time of culture. ALP activity was
conﬁrmed in all groups, hASCs and SSEA-4þhASCs, with and
without sNPs, cultured in osteomedium. A clear increase of the ALP
activity was evident up to 14 days of culture and for increased sNPs
concentrations as demonstrated by the dark purple color (Fig. 6A).
The quantitative analysis of ALP activity, normalized to the total
dsDNA, conﬁrmed the trend of these observations, with a 10-fold
increase at day 14 (Fig. 6C). A slight increase of ALP activity occurred
during initial time points, up to day 10, followed by a burst at day 14
(*p < 0.05) and a successive rapid decrease at day 21. Additionally,
the signiﬁcantly higher ALP activity in SSEA-4þhASCs (*p < 0.05)
when compared to hASCs cultured in the same conditions, and thus
their enhanced predisposition to differentiate towards the osteo-
genic lineage, is noteworthy.
Concerning the cultures in basal medium, the constitutive ALP
activity did not noticeably vary along the time of culture in both
SSEA-4þhASCs and hASCs. However, in the presence of sNPs the
Fig. 5. RT-PCR results for early (RUNX2), intermediate (OPN) and late (OCN) osteo-related markers in SSEA-4þhASCs cultures, in relation to hASCs cultures established in corre-
spondent basal and osteogenic media. In basal medium (A) the expression of these transcripts is up-regulated in the presence of sNPs, in a dose-dependent manner, that also varies
with the gene of interest. (B) Under osteogenic differentiation conditions, a signiﬁcant increase in the expression of these markers was observed both in the absence and the
presence of sNPs. A dependence with the sNPs concentration was observed for all the genes. V depicts statistical difference (*p < 0.05), when compared with hASCs group, ∅
corresponds to statistical differences when compared with SSEA-4þhASCs without sNPs, while u shows the statistical differences when compared with SSEA-4þhASCs in the
presence of 1 mg/mL sNPs.
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strated bymore intense staining at day 14, for the 10 and 100 mg/mL
sNPs formulations (Fig. 6A). The quantitative analysis conﬁrmed
the observed trend. At day 14, a signiﬁcant increase in ALP activity
(*p < 0.05) was observed for SSEA-4þhASCs cultured with
increasing concentrations of sNPs (Fig. 6B).
3.3.3. The effect of sNPs over the deposition of collagenous proteins
and matrix mineralization
The deposition and distribution of the proteins that form the
extracellular matrix was evaluated by Sirius Red/Fast Green stain-
ing, aiming at discriminating the collagenous from the non-
collagenous proteins. When cells (hASCs and SSEA-4þhASCs)
were cultured in basal medium for 21 days, a uniformly distributed
cyan coloration, corresponding to non-collagenous proteins, was
observed. However, in the presence of sNPs, small purple regions,
corresponding to collagen deposition, were observed. In osteogenic
medium cultures, both in the presence and absence of sNPs, the
cyan/purple ratio switched, so that large ﬁbrillar-like collagenous
regions overtook the regions that correspond to non-collagenous
proteins. (Fig. 7A) The qualitative results were conﬁrmed by the
quantiﬁcation of the total amount of collagen deposited in the
different conditions. While no signiﬁcant differences were
observed in the amount of collagen deposited by hASCs and SSEA-
4þhASCs cultured in basal medium, the addition of sNPs led tosigniﬁcantly higher (*p < 0.05) collagenous proteins deposition
(Fig. 7B). Successively higher amounts were detected with
increasing sNPs concentration reaching a nearly 8-fold in the
presence of 100 mg/mL of sNPs. The SSEA-4þhASCs cultured in
osteogenic medium revealed a similar behavior, with cells being
able to deposit a signiﬁcantly higher amount of collagenous pro-
teins (*p < 0.05). The addition of 100 mg/mL sNPs to hASCs and
SSEA-4þhASCs resulted in a 3.4-fold and 2.1-fold increase, respec-
tively when compared to cells cultured without sNPs (Fig. 7C). The
quantiﬁcation of non-collagenous proteins revealed constant levels
of proteins both in basal and osteogenic media, except for the
100 mg/mL sNPs formulation in osteogenic medium which showed
signiﬁcantly higher values than the hASCs and SSEA-4þhASCs
cultured without sNPs (Supplemental Fig. 3AeB).
In order to determine the type of collagen composing the
deposited collagenous matrix, the presence of collagen type I was
evaluated at day 14, 21 and 28 by immunocytochemistry (Fig. 8). In
basal media, only residual collagen type I was detected for both
hASCs and SSEA-4þhASCs. However, when sNPs were added to the
SSEA-4þhASCs, increased evidence of collagen type I was noticed.
By day 28, only small collagen type I depots were identiﬁed in all
conditions, including sNPs in basal medium. On the other hand, in
osteogenic medium, collagen type I was dominantly present in all
conditions. Moreover, an increased and uniformly distributed
deposition seemed to be detected for the SSEA-4þhASCs with the
Fig. 6. Qualitative and quantitative analysis of alkaline phosphatase (ALP) activity during 21 days of culture. (A) NBT/BCIP staining (dark purple) highlights an intense coloration
with the addition of sNPs, suggesting that the sNPs enhance ALP activity. (BeC) The presence of sNPs lead to signiﬁcantly enhanced ALP activity at day 14 of culture in SSEA-4þhASCs
in basal and osteogenic media, when compared to hASCs cultured in the same conditions (*p < 0.05, **p < 0.01, ***p < 0.001). (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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(Supplemental Fig. 3C). When the ratio between collagen type I and
type II was analyzed, the highest percentage of collagen type I was
found for the SSEA-4þhASCs with 100 mg/mL of sNPs in osteogenic
medium. Interestingly the highest percentage of collagen type II
was found for SSEA-4þhASCs treated with 100 mg/mL of sNPs in
basal medium (Supplemental Fig. 3D).
Alizarin Red staining conﬁrmed that in basal medium, matrix
mineralization depots were only detected in the presence of sNPs
(Fig. 9A). Moreover these signiﬁcantly increased with increasing
sNPs concentrations and longer time points (Fig. 9B). At day 28, the
amount of inorganic calcium in the SSEA-4þhASCs culture with
sNPs was signiﬁcantly higher (*p < 0.05) than in the hASCs or SSEA-
4þhASCs cultures without sNPs. In osteogenic medium, signiﬁcant
mineral deposition was observed in the hASCs cultures as evi-
denced by the intensity of the staining. Nonetheless, SSEA-4þhASCs
cultures showed enhanced mineralization levels, with a more
intense overall staining and higher number of mineralized regions
in the presence of the sNPs (Fig. 9A). The extent of mineralization in
osteogenic medium by day 28, 10-fold higher level than in basal
medium, conﬁrmed by signiﬁcant differences (*p < 0.05) betweenSSEA-4þhASCs and hASCs cultures, both in the presence and
absence of sNPs (Fig. 9C).
4. Discussion
One of the goals of bone TE is to design adequate supportive
matrices for skeletal stem cells or progenitor cells to sustain the
repair and regenerate damaged tissue. Focus has been given to AT
as an alternative cell source to bone marrow MSCs [25]. At present,
isolating homogenous stem cell subpopulations from the SVF of
human AT that aremore prone to differentiate into a certain lineage
(osteogenic, chondrogenic, endothelial, etc) is being exploited as an
approach to use this cell source more efﬁciently. So far
CD49dþhASCs [18], CD90þhASCs [20] or CD105hASCs [19] were
shown to possess an enhanced osteogenic differentiation potential
when compared to unsorted cells (hASCs). However, as bone
healing and regeneration relies on heterogeneous cellular in-
teractions (eg. endothelial- and osteoblast-like cells), the use of a
cell source/subpopulation with potential to differentiate towards
these lineages relevant for bone tissue engineering might be ad-
vantageous. Our previous work [21] showed that besides being able
Fig. 7. Detection of proteins produced by hASCs and SSEA-4þhASCs when cultured in basal and osteogenic media for 21 days. (A) Fast Green and Sirius Red staining depicts the
distribution of collagenous (purple) and non-collagenous (cyan) proteins within the matrix. (BeC) Quantiﬁcation of collagenous proteins normalized against the amount of dsDNA.
The osteogenic differentiation of SSEA-4þhASCs is characterized by a signiﬁcantly enhanced collagen production in comparison to the hASCs. The addition of sNPs lead also to an
increased production of collagenous proteins in both basal and osteogenic conditions (*p < 0.05, **p < 0.01, ***p < 0.001).(For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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subpopulation residing within the SVF of the AT could differentiate
into microvascular-like endothelial cells. This dual-differentiation
potential features the possibility to obtain the relevant type of
cells using a single-source and a single step-isolation procedure to
engineer vascularized bone tissue.
Recently, the potential of sNPs (Laponite,
Naþ0:7½ðSi8Mg5:4Li0:3ÞO20ðOHÞ40:7) to induce the osteogenic differ-
entiation of bone marrow stromal cells in the absence of any
external osteoinductive factors was demonstrated [12]. Thus, we
herein propose the use of sNPs as instruments to promote and
improve the osteogenic differentiation of SSEA-4þhASCs.
Intrinsic and extrinsic properties of nanoparticles such as sur-
face area, charge and functionalities, as well as size and shape,
might impact cytotoxicity. Cytotoxicity tests were carried out
considering the threshold of 20% reduction of SSEA-4þhASCs
metabolic activity. Our data is in agreement with previously pub-
lished studies [12]: nanoparticles with negative zeta potential were
shown to be signiﬁcantly less internalized by cells thannanoparticles with positive zeta potential [26]. The cationic surface
of sNPs is responsible for their interactions with the anionic gly-
coproteins and phospholipids of the cell membrane, which possibly
facilitates their internalization [27]. This suggests that the cellular
uptake occurs when sNPs are oriented with their positive side to-
wards the cell membrane, ensuring a low area [28] and their
engulfment and the disguise of the negative facet. However, the use
of positively charged systems remains problematic in vivo as their
interaction with negatively charged serum proteins and red blood
cells may form large clusters and interfere with normal metabolic
processes [29]. In fact, our in vitro data reproduced this observation,
as for sNPs concentrations higher than 100 mg/mL, the formation of
clusters that could hinder the internalization mechanism was
observed. As a consequence, these clusters attached to the cell
membrane, impairing cell cytoskeletal organization and meta-
bolism. At the same time, it is known that the optimal nanoparticle
diameter for cellular uptake is in the order of 25e30 nm [30], which
is in good agreement with the radius reported for the sNPs [12,31],
at concentrations below 100 mg/mL. In addition to being uptaken by
Fig. 8. Representative immunoﬂuorescence images of the detection of collagen type I (green) over time and for the different experimental conditions. The addition of sNPs triggers
the deposition of collagen type I in both basal and osteogenic media. Cell nuclei were counterstained with DAPI (blue). (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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localized around the cellular nuclei, sNPs were also found attached
to the cellular membrane, without affecting the cells ﬁbroblastic-
like morphology. Therefore, the cells-sNPs interaction comprise
the sum of the external contact at the membrane level, and of the
internal effect, due to the engulfed sNPs. In order to isolate these
two types of interactions, complementary experiments were car-
ried out by inhibiting the endocytotic internalization mechanism
using colchicine, an endocytotic restrictive drug. Colchicine is
known to bind tightly to microtubules causing microtubule depo-
lymerization, further affecting the endocytosis mechanism [27].
Based on the narrow sNPs range size, our hypothesis was that the
cellular uptake predominately occurred via clathrin-mediated
endocytosis pathway, as already reported elsewhere [30,32]
(Supplemental Fig. 4). Our data suggests that the interactions that
occur at the membrane level are equally important as the ones that
occur internally. Particularly, it was possible to estimate that for the
100 mg/mL sNPs, both the cytoplasmic effect and external in-
teractions have an equal contribution (approx. 35% each).
Independent of being entrapped within the endosome, attached
to the cell membrane, or in suspension in the culture medium,
particularly at low pH [31,33], sNPs are subjected to constant acidic
and/or enzymatic degradation, dissociating into silicic acid
(Si(OH)4), Naþ, Mg2þ and Liþ. All of these were shown to improvethe osteogenic differentiation by different mechanisms [34e36].
In vitro osteogenic differentiation is characterized by several tem-
poral milestones that demonstrate the commitment of the cells
towards the osteoblastic phenotype. At early stages of differentia-
tion, the activation of the RUNX2 transcription factor occurs to
facilitate the convergence of numerous osteogenic signaling path-
ways [37,38]. Our data features an intense up-regulation of RUNX2
for the SSEA-4þhASCs cultured in osteogenic medium, in compar-
ison to hASCs. Moreover, in the presence of sNPs a signiﬁcantly
higher up-regulation, proportional to the sNPs concentration, was
observed which indicates that the osteogenic differentiation was
triggered due to a signal provided by the sNPs. Interestingly, RUNX2
expression up-regulation was also noted in basal medium at
different time points for the different concentrations of sNPs.
Earlier up-regulation was detected for higher sNPs concentration,
which is in accordance to our previously published data that
showed the osteogenic differentiation of bonemarrow stromal cells
in the absence of any external osteoinductive factors [12].
Considered to be the central control gene within the acquisi-
tion of osteoblast phenotype, RUNX2 directly stimulates ALP ac-
tivity [39] and the up-regulation of osteogenic-related genes such
as OPN or OCN [38,40], and genes responsible for encoding
collagenous-like matrix, mainly constituted of type I collagen [41],
which is a prerequisite for mineralization [42,43]. The follow-up of
Fig. 9. Alizarin Red staining and respective quantiﬁcation of the gradual mineralization of the deposited matrix along the culture. (A) Alizarin Red staining showed an intense
coloration for increased sNPs concentrations. (BeC) Quantiﬁcation of Alizarin Red staining conﬁrmed a signiﬁcant higher matrix mineralization in the SSEA-4þhASCs cultures in the
presence of sNPs, both in basal and osteogenic media (*p < 0.05, **p < 0.01, ***p < 0.001).
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regulation, showed that the nature of the deposited matrix was
dependent on the cell type and/or culture media and/or addition
of sNPs. A maximum of ALP activity was detected, independent ofthe culture media, although at different levels, at day 14, as ex-
pected as an indication of the osteogenic phenotype acquisition
[39,44]. As for RUNX2 expression, sNPs alone lead to increased ALP
activity; however, a plateau was reached when 10 mg/mL sNPs
S.M. Mihaila et al. / Biomaterials 35 (2014) 9087e90999098were used. In opposition to RUNX2, the dependence of the OPN
and OCN expression with the sNPs concentration did not affect its
temporal proﬁle. As expected during osteogenic differentiation
[45], the maximum up-regulation of OPN transcripts was observed
at day 14 while for OCN a peak was detected between days 14
and 21.
Among the dissociation products of sNPs, soluble silicate ions
have been found to stimulate the expression of collagen type I in
osteoblast-like cell cultures [3], while magnesium [35] and lithium
[36,46] were shown to facilitate mineralization [43,47]. Thus, upon
triggering the cells differentiation towards the osteogenic lineage,
it was expected that the sNPs would also affect the nature of the
deposited extracellular matrix (ECM). The deposition of
collagenous-proteins, in detriment of non-collagenous proteins,
gradually took over when SSEA-4þhASCs were cultured together
with sNPs, in basal medium, although the levels observed in oste-
ogenic medium were not reached. As a general remark, collagen
stained by Sirius Red displayed a ﬁbrillar pattern, whereas non-
collagen proteins stained with Fast Green showed a more diffused
pattern. In fact, the deposited matrix under osteogenic conditions
was mainly composed of collagen type I, known to be produced by
developing osteoblast-like cells and an early indicator of the oste-
ogenic differentiation [43], a prevalence of collagen II was detected
when cells were cultured in basal medium.
Different works have shown that the enzymatic activity of ALP
has a direct role in initiating the calciﬁcation process [39,48,49].
Taken together, the ALP enriched cuboid-shaped clusters, the
pattern of collagen deposition and the Alizarin Red staining,
conﬁrmed the conclusion of the differentiation process. This was
achieved with greater efﬁciency for the SSEA-4þhASCs cultures in
the presence of sNPs under osteogenic conditions, as demonstrated
by more than 90% of the culture area depicting the formation of
newmineralized nodules. Nonetheless, the SSEA-4þhASCs cultures
in basal medium with presence of sNPs also generated calcium
depots, indicating successful differentiation of SSEA-4þhASCs into
osteoblast-like cells, although at lower rates than in osteogenic
conditions. Therefore, by applying a single dose of sNPs to cells with
high osteogenic differentiation potential promotes up-regulation of
bone-related markers, which lead to production of enhanced
mineralized matrix.
5. Conclusions
By means of immunomagnetic selection targeting the SSEA-4
surface marker, it is possible to select a subpopulation with high
differentiation potential (SSEA-4þhASCs). Our data suggest that the
SSEA-4þhASCs bear higher osteogenic differentiation potential
than hASCs, which can be further enhanced by the addition of sNPs
in a dose dependent manner. Thus, envisioning bone tissue
regeneration, the association of SSEA-4þhASCs with sNPs harbors
great potential in a TE approach towards the development of highly
mineralized templates using an independent differentiation pro-
cess. Even more, this unique combination can be further exploited
in association with endothelial derived SSEA-4þhASCs and 3D-
templates to design improved bone analogs.
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